Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Veracyte (VCYT) Q3 2026 Earnings Call Transcript (Fool) +++ VERACYTE Aktie +4,53%

EVOLENT HEALTH Aktie

 >EVOLENT HEALTH Aktienkurs 
4.34 EUR    (TradegateBSX)
Ask: 4.38 EUR / 3420 Stück
Bid: 4.3 EUR / 3500 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>EVOLENT HEALTH Performance
1 Woche: +0,3%
1 Monat: +26,6%
3 Monate: +44,4%
6 Monate: +21,1%
1 Jahr: -35,0%
laufendes Jahr: +12,7%
>EVOLENT HEALTH Aktie
Name:  EVOLENT HEALTH A DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US30050B1017 / A14UCN
Symbol/ Ticker:  9EH (Frankfurt) / EVH (NYSE)
Kürzel:  FRA:9EH, ETR:9EH, 9EH:GR, NYSE:EVH
Index:  -
Profil:  Evolent Health Inc Class A Common Stock represents ownership in Evolent Health, a healthcare services company focused on improving care for people with complex medical conditions. The company provides specialty care management, population health solu..
>Volltext..
Marktkapitalisierung:  447.73 Mio. EUR
Unternehmenswert:  1172.7 Mio. EUR
Umsatz:  1866.19 Mio. EUR
EBITDA:  78.36 Mio. EUR
Nettogewinn:  -449.4 Mio. EUR
Gewinn je Aktie:  -4.07 EUR
Schulden:  863.61 Mio. EUR
Liquide Mittel:  123.43 Mio. EUR
Operativer Cashflow:  48.34 Mio. EUR
Bargeldquote:  0.28
Umsatzwachstum:  -1.5%
Gewinnwachstum:  -299.28%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  EVOLENT HEALTH
Letzte Datenerhebung:  05.11.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 113.06 Mio. St.
Frei handelbar: 90.58%
Rückkaufquote: 7.95%
Mitarbeiter: 4200
Umsatz/Mitarb.: 0.4 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 33.55%
Bewertung:
KGV: -
KGV lG: 25.36
KUV: 0.25
KBV: 1.3
PEG-Ratio: -0.01
EV/EBITDA: 14.97
Rentabilität:
Bruttomarge: 11.89%
Gewinnmarge: -24.08%
Operative Marge: -1.33%
Managementeffizenz:
Gesamtkaprendite: -22.78%
Eigenkaprendite: -78.95%
>Peer Group
Gesundheit, Kliniken, Pflegeheime & Gesundheitsdienstleistungen, Onkologie/ Krebs- Behandlung, Herz-Kreislauf- Behandlung/ Kardiologie
 
05.11.26 - 20:00
Evolent Health (EVH) Q3 2026 Earnings Call Transcript (Fool)
 
Oncology and AI-driven efficiencies anchor the quarter's stronger profit picture....
05.11.26 - 16:45
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics (Zacks)
 
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
05.11.26 - 13:27
Evolent Health Non-GAAP EPS of $0.06 in-line, revenue of $725.3M misses by $1.75M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.26 - 13:03
Evolent Announces Third Quarter 2026 Results (PR Newswire)
 
WASHINGTON, Nov. 5, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced......
04.11.26 - 16:33
Evolent Health Q3 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.10.26 - 12:06
Braemar Unveils Highly Qualified Independent Board Slate for Company′s New Chapter (Business Wire)
 
Company urges stockholders to protect the value-creation plan already underway by voting the GOLD proxy cardDALLAS--(BUSINESS WIRE)--Braemar Hotels & Resorts Inc. (NYSE: BHR) (“Braemar” or the “Company”) today announced that its Board of Directors (the “Board”) intends to nominate eight highly qualified, seasoned leaders for election at the Company's 2026 Annual Meeting of Stockholders (the “Annual Meeting”). The slate of eight director candidates includes seven new, highly qualified and independent director nominees: Craig A. Barbarosh was Senior Managing Director of CommonWealth Partners, an $8 billion real estate investment firm, and has served on the board of Sabra Health Care REIT since 2010, where he chairs the Audit Committee. He also chairs the Strategy Committee at Evolent Health and previously served as Vice Chairman of NextGen Healthcare and Chairman of Lifecore Biomedical. He holds a BA from the University of California, Santa Barbara and a JD from the University of the Pacifi...
09.10.26 - 22:33
Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026 (PR Newswire)
 
WASHINGTON, Oct. 9, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its third quarter 2026 financial results on Thursday, November 5, 2026, before market open,......
29.08.26 - 00:01
Insiderhandel: PRESIDENT verkauft Aktien von Evolent Health im Wert von 329460 USD (Insiderkauf)
 
Mccarthy, Daniel Joseph - Vorstand - Tag der Transaktion: 2026-08-26...
13.08.26 - 20:00
Evolent Health (EVH) Q2 2026 Earnings Call Transcript (Fool)
 
Highmark launch drove 47% revenue growth; AI platform reached meaningful scale....
06.08.26 - 16:45
Compared to Estimates, Evolent Health (EVH) Q2 Earnings: A Look at Key Metrics (Zacks)
 
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
06.08.26 - 16:00
Evolent Health (EVH) Tops Q2 Earnings and Revenue Estimates (Zacks)
 
Evolent Health (EVH) delivered earnings and revenue surprises of +300.00% and +6.77%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?...
06.08.26 - 15:12
Earnings Call: Evolent Health übertrifft Q2-Schätzungen und hebt Prognose an – Aktie springt an (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.26 - 14:48
Starke Zahlen und Short Squeeze: Aktie von Evolent Health explodiert vorbörslich (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.26 - 13:12
Evolent Health Non-GAAP EPS of $0.02 beats by $0.04, revenue of $652.2M beats by $52.41M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.26 - 13:03
Evolent Announces Second Quarter 2026 Results (PR Newswire)
 
WASHINGTON, Aug. 6, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced......
23.07.26 - 20:33
Evolent Health drops 16% after Citi downgrade on rising FY2027 Medicaid risk (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.07.26 - 22:33
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 (PR Newswire)
 
WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open,......
03.07.26 - 17:30
Should You Buy Evolent Health (EVH) After Golden Cross? (Zacks)
 
Is it a good or bad thing when a stock experiences a golden cross technical event?...
29.06.26 - 18:15
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength? (Zacks)
 
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road....
13.05.26 - 13:42
Evolent Health übertrifft Gewinnerwartungen in Q1 2026 – Aktie legt deutlich zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Es ist niemand gern alt, und doch will jedermann gern alt werden. - Sprichwort Deutschland
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!